The size of the global veterinary healthcare market is expected to value USD 49.76 billion by 2026 from USD 33.96 billion in 2021, growing at a CAGR of 7.94% during the forecast period. Increased love for pets leads to an upsurge in animal ownership, raising awareness among the people about animal health, and very few animal health drug approval requirements are the major factors driving veterinary healthcare. The growing number of foodborne diseases is also fuelling the animal healthcare market.
Veterinary medicine can be defined as the science associated with diagnosing, treating, and preventing diseases in animals. The scope of Veterinary medicine is broad, covering various animal species, both domestic and wild. The increasing importance of the production of livestock animals is generating growth in the animal healthcare market. An ever-increasing population and a stable economy are expected to increase protein-rich foods, especially in developing countries.
Veterinary healthcare involves providing proper treatment for the animals. There are many key players associated with animal welfare to improve market shares. The cattle health and welfare group, a welfare association, is looking after the cattle health and welfare issues in the United Kingdom.
Also, in the United States, many welfare associates like Winter Haven support the human-animal bond, where they are providing high-quality treatment services.
In developing countries like India, both government and non-government organizations are taking initiatives to improve veterinary healthcare services. For instance, the government and MSD Animal Health are collaborated to control foot and mouth diseases by continuously monitoring the health of livestock animals.
Rising insurance policies for pet healthcare are primarily hiking the growth rate of the global veterinary healthcare market.
Penetration of new policies into pet owners is significantly influencing the demand of this market. In the developed market, the penetration rate of pet insurance policies is very high. For example, in the United States, the need for pet insurance policies is growing at a high CAGR during the forecast period. Similarly, in the UK, the penetration rate of pet insurance is 20%. The introduction of various pet insurance policies is solely increasing visits to veterinary healthcare centers or clinics.
The growing meat consumption rate is anticipated to fuel the market growth.
In emerging countries, there is a huge for livestock animals where there is substantial demand to take care of the health of those animals. These animals should be taken care of to prevent infectious diseases. In addition, livestock animals need vaccines that provide immunity to fight against infections. Rising demand for meat consumption across the globe is one major factor driving the market's growth rate.
Government initiatives to promote healthcare services for animals are propelling the demand of the animal healthcare market.
Many government organizations are taking the initiative to provide excellent veterinary healthcare services. These organizations are also monitoring to launch of various vaccines to avoid infectious diseases like foot and mouth diseases among animals. Rising funds to develop new vaccines by the government are expanding the growth rate of the veterinary healthcare market to the extent.
The shortage of veterinarians is slowly hindering the demand of the market. There is a decreasing number of veterinarians due to fewer training programs. Reluctance to adopt new technologies in undeveloped countries is a significant attribute for veterinarians' shortage in these places. Stringent rules and regulations are a significant challenge. Government authorities are imposing strict rules and regulations to approve a vaccine. It remains a major challenging factor for the key players. Some vaccines are unavailable against livestock vector-borne pathogens is hampering the growth rate of the market. Fluctuations in the availability of raw materials and the unavailability of vaccines for some diseases restrict the market's demand. Additionally, increasing regulation on antibiotics is expected to remain a major restraint for the market. Apart from that, growing costs regulation related to animal testing is also a significant hurdle for the growth of the animal healthcare market.
Increasing investments in veterinary hospitals to ensure quality services is a significant factor anticipated to present growth opportunities for the market. The rise in the concern towards animal healthcare is lavishing the demand of the veterinary healthcare market. Also, growing incidences of various health disorders among animals are ascribed to bolster the market's need. Pet lovers seek for best treatment procedure at any cost, which is also impacting the growth of the market towards positive. Increasing the livestock population is another attribute focused on expanding the demand of the market. Furthermore, people's need for quality poultry products for a healthy lifestyle is likely to extensively outshine the market's need.
COVID-19 impact on the global veterinary healthcare market:
COVID-19 pandemic has negatively impacted the first half of 2020 due to lockdown restrictions and a ban on international flights. With the increasing prevalence to avoid the spread of infectious diseases among animals, there is a significant growth rate for the market during the COVID 19 outbreak. There is an increasing demand to develop a vaccine to prevent chronic diseases from pet owners. It is also essential to protect the livestock animals from these infectious diseases, which positively impacts the growth rate of the veterinary healthcare market. However, it is projected that the market will fall into a normal position by 2021.
Market Size Available
2020 to 2026
2021 to 2026
By Product, Animal Type, Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
North America, Europe, APAC, Latin America, Middle East & Africa
Market Leaders Profiled
Merck & Co., Inc., Bayer AG, Boehringer Ingelheim GmbH, Cargill, Inc., Ceva Santé Animale, Novasep, Eli Lilly and Company, Koninklijke DSM N.V., Novartis AG, Nutreco N.V., Sanofi S.A., Sequent Scientific Ltd., Virbac S.A., Vétoquinol S.A. and Zoetis Inc.
This research report on the global veterinary healthcare market has been segmented and sub-segmented into the following categories and evaluated market size and forecast for each segment until 2026.
Veterinary Healthcare Market – By Product:
Based on the product, the Pharmaceuticals segment is holding dominant shares of the veterinary healthcare market. The increasing production rate of vaccines and drugs in pharmaceutical companies mainly prompts the demand for this segment. Rising awareness in manufacturing different products in significantly less time is also escalating the growth of the market. Increasing incidences of various health disorders among animals are surging the demand of this segment. Furthermore, increasing pet ownership is bolstering the need for this market.
Vaccines sub-segment is leading with the dominant shares of the market. Feed additives are estimated to have significant growth opportunities in the coming years, increasing demand for quality meat production.
Veterinary Healthcare Market – By Animal Type:
Based on Animal Type, Livestock animal type is growing faster from the past few years and has a significant growth rate in the coming years. The shifting trend towards protein-rich foods, which are directly available from poultry products like eggs and others, is leveraging the demand of the veterinary healthcare market. Also, growing capita income in developed and developing countries boosts the growth rate of this market. The rising meat consumption rate is the key factor fuelling the demand of the market. Growing awareness over the availability of different treatment procedures for animals enhances the growth rate of this market. Also, the companion animals segment is to have the fastest growth opportunities in the coming years.
Veterinary Healthcare Market – By Region:
Geographically, Europe and North America are the dominating markets for veterinary healthcare accounting for a combined share of around 60% of the market due to several pet owners. However, Asia-Pacific is one of the significant producers of animal meat and is estimated to be the fastest-growing region during the forecast period.
North America is holding the dominant share of the global veterinary healthcare market due to increasing chronic diseases among animals. The US is the leading country with the highest shares of the market. The introduction of pet insurance policies and creating awareness over the availability of the different treatment processes for pet animals are anticipated to fuel the market's growth rate. Escalating expenditure on veterinary healthcare in the US is solely accelerating the market demand. According to the American Pet Product Association, the pet market demand was increased by 4.1% during 2016-2017. Canada is next to the US in leading the shares of the veterinary healthcare market. Some people also treat animals as family members in these countries, hugely impacting the market's growth rate.
Europe is following North America in ruling the largest shares of the market. Different key strategies by market players to impel the shares are attributed to impel the market's growth rate. Launching generic drugs due to increasing demand from pet owners is to propel the demand growth rate of the market. The expanding portfolio of the present key players in developed and developing countries also tremendously emphasizes market demand.
Asia pacific is thriving to hit the highest CAGR in the foreseen years. The rise in the support from the government organizations through funds and focus on developing new drugs or vaccines in favor of the end-user is majorly lavishing the growth rate of the veterinary healthcare market.
KEY MARKET PLAYERS:
Notable companies which occupied the majority of the shares in the Global Veterinary Healthcare Market profiled in this report are Merck & Co., Inc., Bayer AG, Boehringer Ingelheim GmbH, Cargill, Inc., Ceva Santé Animale, Novasep, Eli Lilly and Company, Koninklijke DSM N.V., Novartis AG, Nutreco N.V., Sanofi S.A., Sequent Scientific Ltd., Virbac S.A., Vétoquinol S.A., and Zoetis Inc.
MAJOR HAPPENINGS IN THIS MARKET IN THE RECENT PAST:
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Feed Additives
188.8.131.52 Medical Feed Additives
184.108.40.206 Nutritional Feed Additives
5.1.3 Y-o-Y Growth Analysis, By Product
5.1.4 Market Attractiveness Analysis, By Product
5.1.5 Market Share Analysis, By Product
5.2 Animal Type
5.2.1 Livestock Animals
5.2.2 Companion Animals
5.2.3 Y-o-Y Growth Analysis, By Animal Type
5.2.4 Market Attractiveness Analysis, By Animal Type
5.2.5 Market Share Analysis, By Animal Type
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Product
22.214.171.124 By Animal Type
6.1.4 Market Attractiveness Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Product
184.108.40.206 By Animal Type
6.1.5 Market Share Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Product
22.214.171.124 By Animal Type
6.2 North America
6.1.2 United States
6.3.6 South Korea
6.5 Latin America
6.4.5 Rest of Latin America
6.6 Middle East & Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 MSD Animal Health
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Bayer AG
8.3 Boehringer Ingelheim GmbH
8.4 Ceva Santé Animale
8.5 Eli Lilly and Company
8.6 Cargill, Inc
8.8 Koninklijke DSM N.V
8.9 Nutreco N.V.
8.10 SeQuent Scientific Ltd.
8.11 Virbac S.A.
8.12 Vétoquinol S.A.
8.13 Zoetis Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures